Driving Innovation Forward
We embrace cutting-edge AI to create smarter, more efficient automation solutions.
AXIOM
Early-Stage
We build AI systems that predict downstream toxicity from early-stage experimental data to improve decision-making in drug development.
Our values shape everything we do. From innovation to integrity, we’re committed to building AI solutions that empower businesses and drive real impact.
We embrace cutting-edge AI to create smarter, more efficient automation solutions.
Trust and transparency are at the core of everything we do for our clients.
We use causal modeling and biological pathway knowledge to distinguish benign signals from true toxicity risk.
Founding team with experience across biology, AI, and software engineering.